Crohn's disease: open trials in Georgia

• NCT06226883

  A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 2 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

  High Technology Hospital Medcenter LLC, Batumi · Emergency Cardiology Center by Academician G. Chapidze LLC, Tbilisi · LTD The First Medical Center, Tbilisi · LTD Aversi Clinic, Tbilisi · Ltd "Institute of Clinical Cardiology", Tbilisi · LEPL The First University Clinic of Tbilisi State Medical University, Tbilisi

  Registry updated 2026-11-04

• NCT06651281

  Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  ARENSIA Exploratory Medicine Georgia (Site 1104), Tbilisi

  Registry updated 2026-11-03

• NCT06430801

  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  LTD High Technology Hospital Medcenter (Site 0802), Batumi · Caucasus Medical Centre (Site 0801), Tbilisi · Caraps Medline (Site 0803), Tbilisi · New Hospitals (Site 0800), Tbilisi

  Registry updated 2026-11-02

• NCT07184931

  An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 3 · Sanofi

  Kutaisi · Tbilisi · Tbilisi · Tbilisi · Tbilisi · Tbilisi · Tbilisi · Tbilisi · Tbilisi

  Registry updated 2026-10-21

• NCT07184944

  A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 3 · Sanofi

  Tbilisi · Tbilisi · Tbilisi · Tbilisi · Tbilisi · Tbilisi

  Registry updated 2026-10-21

• NCT07113522

  A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  Trial Treatment · Phase 2 · Mirador Therapeutics, Inc.

  Kutaisi · Marneuli · Tbilisi

  Registry updated 2026-03-12

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error